Professor Andreas Baumbach

Profile

Professor Andrea Baumbach is active in coronary and structural intervention, and has published extensively in the field of interventional research covering preclinical, first in man, pivotal and post market studies. He has an interest in device innovation and regulatory pathways.

Professor Baumbach has a strong commitment to training and education. He is on the board of directors of the largest interventional congress EuroPCR and PCR London Valves. He Past President of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Research

Group members

• Prof Christos Bourantas
• Dr Anantharam Ramasary
• Dr Nida Ahmed
• Dr Ratesh Bajaj
• Dr Kush Patel

Summary

Active in first in human trials, as well as large scale multinational, multi-centre randomised clinical trial evaluation of novel devices.

Publications

• Bennett J, Thornton GD, Nitsche C et al. (2024). Left Ventricular Hypertrophy in Aortic Stenosis: Early Cell and Matrix Regression 2 Months Post-Aortic Valve Replacement.

  
  

  DOI: 10.1161/circimaging.124.017425

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103374
• Tufaro V, Torii R, Aben J-P et al. (2024). Can fast wall shear stress computation predict adverse cardiac events in patients with intermediate non-flow limiting stenoses?.

  
  

  DOI: 10.1016/j.atherosclerosis.2024.119099

  
  

  QMRO:
• Ramasamy A, Parasa R, Sokooti H et al. . Computed tomography versus near-infrared spectroscopy for the assessment of coronary atherosclerosis..

  
  

  DOI: 10.4244/eij-d-24-00096

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103385
• van Royen N, Amat-Santos IJ, Hudec M et al. (2024). Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosis..

  
  

  DOI: 10.4244/eij-d-24-00951

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103384
• Kelham M, Beirne A-M, Rathod KS et al. (2024). CTCA Prior to Invasive Coronary Angiography in Patients With Previous Bypass Surgery: Patient-Related Outcomes, Imaging Resource Utilization, and Cardiac Events at 3 Years From the BYPASS-CTCA Trial.

  
  

  DOI: 10.1161/circinterventions.124.014142

  
  

  QMRO:
• Tsai T-Y, Serruys PW, Wykrzykowska J et al. (2024). Temporal trend and regional disparity in the investigations for stable chest pain in Europe: An insight from the PIONEER IV trial.

  
  

  DOI: 10.1016/j.jcct.2024.10.002

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100895
• Patel KP, Rathod KS, Lansky AJ et al. (2024). Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Replacement: A Review.

  
  

  DOI: 10.1161/strokeaha.124.047149

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100893
• Kelham M, Beirne A-M, Rathod KS et al. (2024). OP1 The use of computed tomography coronary angiography as a gatekeeper to predict the need for invasive coronary angiography in patients with previous CABG presenting with acute coronary syndromes. OP1 The use of computed tomography coronary angiography as a gatekeeper to predict the need for invasive coronary angiography in patients with previous CABG presenting with acute coronary syndromes

  
  

  DOI: 10.1136/heartjnl-2024-bsci.1

  
  

  QMRO:
• Ramasamy A, Pugliese F, Tanboga IH et al. (2024). Head-to-Head Comparison of Near-Infrared Spectroscopy–Intravascular Ultrasound and Coronary Computed Tomography Angiography in Assessing Atheroma Characteristics.

  
  

  DOI: 10.1016/j.jcmg.2024.07.005

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99914
• Baumbach A, Patel KP, Rudolph TK et al. . Aortic regurgitation: from mechanisms to management..

  
  

  DOI: 10.4244/eij-d-23-00840

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100589

Collaborators

External

• Meril Life
• Jenavalve
• Microport

Disclosures

• Institutional Research Support: Abbott Vascular
• Consultation and Speaker Fees: Astra Zeneca, Sinomed, Microport, Medtronic, Faraday Pi-Cardia, Biosensors, Jenavalve